1
|
Derangeon M, Montnach J, Cerpa CO, Jagu B, Patin J, Toumaniantz G, Girardeau A, Huang CLH, Colledge WH, Grace AA, Baró I, Charpentier F. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. Cardiovasc Res 2017; 113:464-474. [PMID: 28339646 DOI: 10.1093/cvr/cvx026] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2015] [Accepted: 02/16/2017] [Indexed: 01/12/2023] Open
Abstract
Aims Loss-of-function mutations in SCN5A, the gene encoding NaV1.5 channel, have been associated with inherited progressive cardiac conduction disease (PCCD). We have proposed that Scn5a heterozygous knock-out (Scn5a+/-) mice, which are characterized by ventricular fibrotic remodelling with ageing, represent a model for PCCD. Our objectives were to identify the molecular pathway involved in fibrosis development and prevent its activation. Methods and results Our study shows that myocardial interstitial fibrosis occurred in Scn5a+/- mice only after 45 weeks of age. Fibrosis was triggered by transforming growth factor β (TGF-β) pathway activation. Younger Scn5a+/- mice were characterized by a higher connexin 43 expression than wild-type (WT) mice. After the age of 45 weeks, connexin 43 expression decreased in both WT and Scn5a+/- mice, although the decrease was larger in Scn5a+/- mice. Chronic inhibition of cardiac sodium current with flecainide (50 mg/kg/day p.o) in WT mice from the age of 6 weeks to the age of 60 weeks did not lead to TGF-β pathway activation and fibrosis. Chronic inhibition of TGF-β receptors with GW788388 (5 mg/kg/day p.o.) in Scn5a+/- mice from the age of 45 weeks to the age of 60 weeks prevented the occurrence of fibrosis. However, current data could not detect reduction in QRS duration with GW788388. Conclusion Myocardial fibrosis secondary to a loss of NaV1.5 is triggered by TGF-β signalling pathway. Those events are more likely secondary to the decreased NaV1.5 sarcolemmal expression rather than the decreased Na+ current per se. TGF-β receptor inhibition prevents age-dependent development of ventricular fibrosis in Scn5a+/- mouse.
Collapse
Affiliation(s)
- Mickael Derangeon
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Jérôme Montnach
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Cynthia Ore Cerpa
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Benoit Jagu
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Justine Patin
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Gilles Toumaniantz
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Aurore Girardeau
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Christopher L H Huang
- The Section of Cardiovascular Biology, Departments of Biochemistry and Physiology, University of Cambridge, Downing street, Cambridge CB23EG, UK
| | - William H Colledge
- The Section of Cardiovascular Biology, Departments of Biochemistry and Physiology, University of Cambridge, Downing street, Cambridge CB23EG, UK
| | - Andrew A Grace
- The Section of Cardiovascular Biology, Departments of Biochemistry and Physiology, University of Cambridge, Downing street, Cambridge CB23EG, UK
| | - Isabelle Baró
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France
| | - Flavien Charpentier
- INSERM, UMR1087, l'institut du thorax, quai Moncousu, Nantes F-44000, France.,CNRS, UMR6291, quai Moncousu, Nantes F-44000, France.,Université de Nantes, quai Moncousu, Nantes F-44000, France.,CHU Nantes, Alexis Ricordeau, Nantes F-44000, France
| |
Collapse
|
3
|
Montaudon E, Dubreil L, Lalanne V, Jagu B, Toumaniantz G, Thorin C, Henrion D, Desfontis JC, Martignat L, Mallem MY. Effects of long-term active immunization with the second extracellular loop of human β 1- or β 3-adrenoceptors in thoracic aorta and mesenteric arteries in Lewis rats. Vascul Pharmacol 2016; 87:129-138. [PMID: 27620808 DOI: 10.1016/j.vph.2016.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2016] [Revised: 08/18/2016] [Accepted: 09/05/2016] [Indexed: 10/21/2022]
Abstract
OBJECTIVE To evaluate whether active immunization producing β1- or β3-antibodies (β1-ABs and β3-ABs) detected in sera of patients with dilated cardiomyopathies has deleterious effects on vascular reactivity in Lewis rat thoracic aorta (TA) and small mesenteric arteries (SMA). DESIGN AND METHOD Lewis rats were immunized for 6months with peptidic sequences corresponding to the second extracellular loop of β1- and β3-adrenoceptors (ARs). During the immunization, systolic blood pressure (SBP) was monitored using the tail cuff method. The vascular reactivity of immunized rats was assessed by ex vivo studies on SMA and TA using various β-AR agonists, phenylephrine and KCl. RESULTS The immunizations producing functional β1-ABs and β3-ABs did not affect the SBP. However, in TA from β1-AR-immunized rats, the relaxations mediated by dobutamine and salbutamol were significantly impaired in comparison with adjuvant rats whereas nebivolol-induced relaxation was not modified. Moreover, phenylephrine and KCl-mediated contractions were enhanced in these rats. In contrast, immunization with β3-AR peptide led to the increase of relaxations induced by dobutamine in TA but did not change those induced by salbutamol and nebivolol. Surprisingly, in SMA from both rats immunized with β1- or β3-peptides, relaxations induced by the various β-agonists were not changed whereas phenylephrine and KCl-mediated contractions were impaired. CONCLUSIONS Our study shows that β1- and β3-ABs can affect vascular reactivity. β1-ABs would have a pathogenic action whereas β3-ABs would have a beneficial effect on aorta reactivity.
Collapse
Affiliation(s)
- E Montaudon
- LUNAM University, Oniris, UPSP 5304 of Animal Pathophysiology and Functional Pharmacology, Atlanpôle La Chantrerie, BP 40706, 44307 Nantes, France
| | - L Dubreil
- LUNAM University, Oniris, INRA UMR U703, PanTHER, Atlanpôle La Chantrerie, BP 40706, 44307 Nantes, France
| | - V Lalanne
- LUNAM University, Oniris, UPSP 5304 of Animal Pathophysiology and Functional Pharmacology, Atlanpôle La Chantrerie, BP 40706, 44307 Nantes, France
| | - B Jagu
- LUNAM University, INSERM, UMR 1087/CNRS 6291 Institut du Thorax, F44007 Nantes, France
| | - G Toumaniantz
- LUNAM University, INSERM, UMR 1087/CNRS 6291 Institut du Thorax, F44007 Nantes, France
| | - C Thorin
- LUNAM University, Oniris, UPSP 5304 of Animal Pathophysiology and Functional Pharmacology, Atlanpôle La Chantrerie, BP 40706, 44307 Nantes, France
| | - D Henrion
- LUNAM University, CNRS UMR 6214, INSERM U1083, F-49000 Angers, France
| | - J-C Desfontis
- LUNAM University, Oniris, UPSP 5304 of Animal Pathophysiology and Functional Pharmacology, Atlanpôle La Chantrerie, BP 40706, 44307 Nantes, France
| | - L Martignat
- LUNAM Univsersity, Oniris, UPSP, Sanitary Safety in Biotechnologies of the Reproduction, La Chantrerie, BP 40706, 44307 Nantes, France
| | - M Y Mallem
- LUNAM University, Oniris, UPSP 5304 of Animal Pathophysiology and Functional Pharmacology, Atlanpôle La Chantrerie, BP 40706, 44307 Nantes, France.
| |
Collapse
|